CLINICAL DOWNSTAGING AFTER NEOADJUVANT M-VAC FOR TRANSITIONAL CELL-CARCINOMA OF THE UROTHELIUM

被引：1
|
作者：
SCHER, HI
FAIR, WR
YAGODA, A
STERNBERG, CN
MORSE, MJ
HERR, HW
SOGANI, PC
HOLLANDER, PS
WHITMORE, WF
机构：
来源：
JOURNAL OF UROLOGY | 1987年 / 137卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(17)75363-3
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A157 / A157
页数：1
相关论文
共 50 条
  • [21] THE ASSOCIATION OF INVERTED PAPILLOMA AND TRANSITIONAL CELL-CARCINOMA OF THE UROTHELIUM
    STEIN, BS
    ROSEN, S
    KENDALL, AR
    JOURNAL OF UROLOGY, 1984, 131 (04): : 751 - 752
  • [22] TRANSITIONAL CELL CARCINOMATOUS MENINGITIS AFTER M-VAC (METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN) CHEMOTHERAPY
    BISHOP, JR
    MOUL, JW
    MALDONADO, L
    MCLEOD, DG
    UROLOGY, 1990, 36 (04) : 373 - 377
  • [23] BLOOD-GROUP ANTIGENS IN UROTHELIUM IN TRANSITIONAL CELL-CARCINOMA
    GIRALDO, AA
    RUBY, SG
    HUMES, JJ
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 1983, 13 (04): : 307 - 314
  • [24] Validation study of the prediction system for clinical response of M-VAC neoadjuvant chemotherapy
    Takata, Ryo
    Katagiri, Toyomasa
    Kanehira, Mitsugu
    Shuin, Taro
    Miki, Tsuneharu
    Namiki, Mikio
    Kohri, Kenjiro
    Tsunoda, Tatsuhiko
    Fujioka, Tomoaki
    Nakamura, Yusuke
    CANCER SCIENCE, 2007, 98 (01) : 113 - 117
  • [25] Neo-adjuvant M-VAC chemotherapy and bladder preservation for muscle infiltrating transitional cell carcinoma (TCC) of the bladder
    Sternberg, C
    Pansadoro, V
    Lauretti, S
    Platania, A
    Giannarelli, D
    Rossetti, A
    DeCarli, P
    Cancrini, A
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1142 - 1142
  • [26] Anatomic site of primary transitional cell carcinoma (TCC) does not affect probability of response to M-Vac or survival.
    McCaffrey, JA
    Dodd, PM
    Herr, H
    Vlamis, V
    Mazumdar, M
    Higgins, G
    Scher, HI
    Bajorin, DF
    JOURNAL OF UROLOGY, 1998, 159 (05): : 166 - 166
  • [27] Study of the Prediction System for Clinical Response to M-VAC Neoadjuvant Chemotherapy for Bladder Cancer
    Takata, R.
    Obara, W.
    Fujioka, T.
    AKTUELLE UROLOGIE, 2010, 41 : S41 - S45
  • [28] PERIOPERATIVE METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN (M-VAC) FOR POOR RISK TRANSITIONAL CELL-CARCINOMA OF THE BLADDER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP PILOT-STUDY
    DREICER, R
    MESSING, EM
    LOEHRER, PJ
    TRUMP, DL
    JOURNAL OF UROLOGY, 1990, 144 (05): : 1123 - 1127
  • [29] CYTOLOGY IN DIAGNOSIS AND FOLLOWUP OF TRANSITIONAL CELL-CARCINOMA OF UROTHELIUM - REVIEW WITH A CASE SERIES
    LEWIS, RW
    JACKSON, AC
    MURPHY, WM
    LEBLANC, GA
    MEEHAN, WL
    JOURNAL OF UROLOGY, 1976, 116 (01): : 43 - 46
  • [30] Cure of undifferentiated small cell carcinoma of the urinary bladder with M-VAC chemotherapy
    Nejat, RJ
    Purohit, R
    Goluboff, ET
    Petrylak, D
    Rubin, MA
    Benson, MC
    UROLOGIC ONCOLOGY, 2001, 6 (02): : 53 - 55
12345